PERSPECTA

News from every angle

← Back to headlines

Eli Lilly Dominates Obesity Market While Pfizer Prepares to Compete

Eli Lilly currently holds a dominant position in the obesity drug market, while Pfizer has made strategic investments to compete in the sector in the near future.

22 Jun, 20:02 — 22 Jun, 20:02
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual64d ago

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

Read full article →

Related Stories

Par Pacific to Sell Laramie Energy Assets for $485 Million

27m ago

Executives at Precigen and RingCentral Sell Company Shares

28m ago

Box Reports Strong Q2 2026 Revenue, Lifts Full-Year Outlook

33m ago

ECB and BOJ Expected to Raise Interest Rates in September

41m ago